FP-025
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for FP-025, covering 2024-01-05 to 2024-05-30. Get the full timeline:
Most recent: Clinical Trial Update: The Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma. [Phase 2]